Showing 301 - 320 results of 67,383 for search '(( 50 ((we decrease) OR (nn decrease)) ) OR ( 5 ((nm decrease) OR (a decrease)) ))', query time: 0.87s Refine Results
  1. 301

    ATP assay. by Dong Ma (584680)

    Published 2020
    Subjects:
  2. 302
  3. 303
  4. 304
  5. 305
  6. 306

    Surface SiO<sub>2</sub> Thickness Controls Uniform-to-Localized Transition in Lithiation of Silicon Anodes for Lithium-Ion Batteries by Manuel Schnabel (4888426)

    Published 2020
    “…For 2–3 nm SiO<sub>2</sub>, SEI formation above 0.1 V is suppressed, but a hold at low or negative voltages can initiate charge transfer whereupon SEI formation and uniform lithiation occur. …”
  7. 307

    Inverse relationship between poison exon usage and expression of multiple sodium channels during mouse brain development. by Yuliya Voskobiynyk (9954619)

    Published 2021
    “…<p>(A) <i>Scn1a</i> transcripts including exon 20N are highly expressed in the developing mouse brain and decrease dramatically after birth (aqua bars), with a corresponding developmental increase in <i>Scn1a</i> expression (blue bars). …”
  8. 308
  9. 309

    Decreased activity of FASII favors the cold growth of the <i>ΔcshA</i> strain. by Vanessa Khemici (814639)

    Published 2020
    “…<i>fapR</i> mRNA levels were quantified by RT-qPCR using 16S rRNA as reference gene on total RNAs extracted from <i>wt</i> strain (PR01), <i>ΔcshA</i> strain (PR01-ΔcshA), and suppressor strains <i>ΔcshA/accC</i><sup><i>M385V</i></sup> (C51), <i>ΔcshA/accC</i><sup><i>T183I</i></sup> (sup30), <i>ΔcshA/accD</i><sup><i>F253V</i></sup> (sup17), <i>ΔcshA/accD</i><sup><i>A164V</i></sup> (sup16), <i>ΔcshA/birA</i><sup><i>D320F-FsX28</i></sup> (C58), <i>ΔcshA/birA</i><sup><i>R280stop</i></sup> (sup1) and <i>ΔcshA/bioY</i><sup><i>P123R-FsX1</i></sup> (C66), all at exponential growth phase in MH medium at 25°C. n = 5 for <i>ΔcshA</i>, <i>4 for wt</i> and 3 for all others. …”
  10. 310

    S1 Dataset - by Nelmo Jordão Manjate (16324619)

    Published 2023
    “…We conducted a retrospective cost analysis from the provider’s perspective using a bottom-up, micro-costing approach, and compared the direct costs of two nasopharyngeal Ag-RDTs (Panbio and Standard Q) against the costs of three nasal Ag-RDTs (Panbio, COVIOS and LumiraDx), and RT-PCR. …”
  11. 311
  12. 312
  13. 313
  14. 314

    Evaluation index results for the JS-10 phantom. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…In the NEMA body phantom, contrast improved with acquisition times of ≥30 s/view, and the CNR increased as noise declined with longer acquisition times. At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
  15. 315

    NEMA IEC body phantom. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…In the NEMA body phantom, contrast improved with acquisition times of ≥30 s/view, and the CNR increased as noise declined with longer acquisition times. At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
  16. 316

    Relationship between contrast, noise, and CNR. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…In the NEMA body phantom, contrast improved with acquisition times of ≥30 s/view, and the CNR increased as noise declined with longer acquisition times. At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
  17. 317

    JS-10 phantom. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…In the NEMA body phantom, contrast improved with acquisition times of ≥30 s/view, and the CNR increased as noise declined with longer acquisition times. At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
  18. 318

    The raw data used for the analyses in this study. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…In the NEMA body phantom, contrast improved with acquisition times of ≥30 s/view, and the CNR increased as noise declined with longer acquisition times. At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
  19. 319

    FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

    Published 2019
    “…<p>(A) HuH6 cells (2.5 x 10<sup>6</sup> cells in 25% Matrigel) were injected subcutaneously into the right flank of 6-week-old female athymic nude mice. …”
  20. 320

    Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors by Stanislav Andreev (11067165)

    Published 2021
    “…Here, by addressing a high-energy water, we improved the IC<sub>50</sub> value of our co-crystallized glycogen synthase kinase-3β (GSK-3β) inhibitor by nearly two orders of magnitude. …”